Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia
Condition: Severe Aplastic Anemia (SAA) Interventions: Drug: eltrombopag; Drug: rabbit anti-thymocyte globulin (r-ATG); Drug: cyclosporine A (CsA) Sponsor: Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials